Molecular Partners AG ( MLLCF) - Key Metrics
MLLCF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.35 | -$0.27 | -$0.27 |
| 2026Q1 | $0 | -$0.35 | -$0.38 | -$0.38 |
| 2025Q4 | $0 | -$0.34 | -$0.29 | -$0.29 |
| 2025Q3 | $0 | -$0.32 | -$0.27 | -$0.27 |
| 2025Q2 | $0 | -$0.55 | -$0.35 | -$0.35 |
MLLCF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.08 |
| 2026Q1 | 0% | -1.28 |
| 2025Q4 | 0% | -2.04 |
| 2025Q3 | 0% | -2.17 |
| 2025Q2 | 0% | -1.49 |
MLLCF
Price: $4.01
52 week price:
Earnings Per Share: -1.68 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 150.4 million